PLRX
Pliant Therapeutics Inc
NASDAQ: PLRX · HEALTHCARE · BIOTECHNOLOGY
$1.21
+0.00% today
Updated 2026-04-29
Market cap
$74.92M
P/E ratio
—
P/S ratio
3,071.82x
EPS (TTM)
$-2.43
Dividend yield
—
52W range
$1 – $2
Volume
0.6M
Pliant Therapeutics Inc (PLRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-16.92M | $-28.33M | $-2.75M | $-37.27M | $-75.44M | $-94.63M | $-116.36M | $-155.50M | $-128.34M |
| Capital expenditures | $1.41M | $2.32M | $964000.00 | $1.53M | $1.95M | $1.76M | $921000.00 | $3.85M | $374000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $33000.00 | $228000.00 | $1.83M | $3.90M | $10.44M | $22.60M | $44.48M | $37.63M | $26.23M |
| Free cash flow | $-18.33M | $-30.65M | $-3.71M | $-38.80M | $-77.40M | $-96.39M | $-117.28M | $-159.35M | $-128.71M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-34.92M | $783000.00 | $-17.98M | — | — | — |